☰

Yicheng Mao, Ph.D. - Publications

Affiliations: 
2012 Pharmacy Ohio State University, Columbus, Columbus, OH 
Area:
Pharmacy
Tree Info Grants Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mani R, Mao Y, Frissora FW, Chiang CL, Wang J, Zhao Y, Wu Y, Yu B, Yan R, Mo X, Yu L, Flynn J, Jones J, Andritsos L, Baskar S, et al. Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia. Leukemia. 29: 346-55. PMID 24947019 DOI: 10.1038/leu.2014.199  0.6
2014 Mao Y, Wang J, Zhao Y, Yan R, Li H, Chen CS, Lee RJ, Byrd JC, Lee LJ, Muthusamy N, Phelps MA. Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 98: 160-5. PMID 24927402 DOI: 10.1016/J.Jpba.2014.05.022  0.485
2014 Mao Y, Wang J, Zhao Y, Wu Y, Kwak KJ, Chen CS, Byrd JC, Lee RJ, Phelps MA, Lee LJ, Muthusamy N. A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 393-400. PMID 23969101 DOI: 10.1016/J.Nano.2013.08.001  0.616
2013 Wu Y, Kwak KJ, Agarwal K, Marras A, Wang C, Mao Y, Huang X, Ma J, Yu B, Lee R, Vachani A, Marcucci G, Byrd JC, Muthusamy N, Otterson G, et al. Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beacons. Analytical Chemistry. 85: 11265-74. PMID 24102152 DOI: 10.1021/Ac401983W  0.531
2013 Yu B, Mao Y, Yuan Y, Yue C, Wang X, Mo X, Jarjoura D, Paulaitis ME, Lee RJ, Byrd JC, Lee LJ, Muthusamy N. Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells. Biomaterials. 34: 6185-93. PMID 23726226 DOI: 10.1016/J.Biomaterials.2013.04.063  0.578
2013 Wu Y, Crawford M, Mao Y, Lee RJ, Davis IC, Elton TS, Lee LJ, Nana-Sinkam SP. Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer. Molecular Therapy. Nucleic Acids. 2: e84. PMID 23591808 DOI: 10.1038/Mtna.2013.14  0.343
2013 Mao Y, Triantafillou G, Hertlein E, Towns W, Stefanovski M, Mo X, Jarjoura D, Phelps M, Marcucci G, Lee LJ, Goldenberg DM, Lee RJ, Byrd JC, Muthusamy N. Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 347-56. PMID 23209030 DOI: 10.1158/1078-0432.Ccr-12-2046  0.63
2013 Yu B, Mao Y, Bai LY, Herman SE, Wang X, Ramanunni A, Jin Y, Mo X, Cheney C, Chan KK, Jarjoura D, Marcucci G, Lee RJ, Byrd JC, Lee LJ, et al. Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia. Blood. 121: 136-47. PMID 23165478 DOI: 10.1182/Blood-2012-01-407742  0.638
2013 Mani R, Mao Y, Frissora FW, Chiang C, Wang J, Zhao Y, Wu Y, Yu B, Yan R, Mo X, Baskar S, Rader C, Phelps MA, Lee RJ, Chen C, et al. Tumor Antigen ROR1 Targeted Delivery Of FTY720 Derivative OSU-2S Prolongs Survival In ROR1 Engineered Mouse Model Of Chronic Lymphocytic Leukemia Blood. 122: 4168-4168. DOI: 10.1182/Blood.V122.21.4168.4168  0.61
2012 Yu B, Hsu SH, Zhou C, Wang X, Terp MC, Wu Y, Teng L, Mao Y, Wang F, Xue W, Jacob ST, Ghoshal K, Lee RJ, Lee LJ. Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials. 33: 5924-34. PMID 22652024 DOI: 10.1016/J.Biomaterials.2012.05.002  0.373
2012 Wu Y, Li L, Mao Y, Lee LJ. Static micromixer-coaxial electrospray synthesis of theranostic lipoplexes. Acs Nano. 6: 2245-52. PMID 22320282 DOI: 10.1021/Nn204300S  0.348
2012 Zhou C, Mao Y, Sugimoto Y, Zhang Y, Kanthamneni N, Yu B, Brueggemeier RW, Lee LJ, Lee RJ. SPANosomes as delivery vehicles for small interfering RNA (siRNA). Molecular Pharmaceutics. 9: 201-10. PMID 22149175 DOI: 10.1021/Mp200426H  0.337
2012 Woyach JA, Stefanovski MR, Goettl V, Ruppert AS, Smucker KA, Smith LL, Dubovsky JA, Towns WH, MacMurray J, Davis ME, Mao Y, Chang BY, Buggy JJ, Byrd JC, Johnson AJ. Global Inhibition of Bruton's Tyrosine Kinase (BTK) Delays the Development and Expansion of Chronic Lymphocytic Leukemia (CLL) in the TCL1 Mouse Model of Disease Blood. 120: 183-183. DOI: 10.1182/Blood.V120.21.183.183  0.41
2011 Alinari L, Mahoney E, Patton J, Zhang X, Huynh L, Earl CT, Mani R, Mao Y, Yu B, Quinion C, Towns WH, Chen CS, Goldenberg DM, Blum KA, Byrd JC, et al. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death. Blood. 118: 6893-903. PMID 22042694 DOI: 10.1182/Blood-2011-06-363879  0.591
2011 Wu Y, Ho YP, Mao Y, Wang X, Yu B, Leong KW, Lee LJ. Uptake and intracellular fate of multifunctional nanoparticles: a comparison between lipoplexes and polyplexes via quantum dot mediated Förster resonance energy transfer. Molecular Pharmaceutics. 8: 1662-8. PMID 21740056 DOI: 10.1021/Mp100466M  0.316
2011 Wu Y, Crawford M, Yu B, Mao Y, Nana-Sinkam SP, Lee LJ. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Molecular Pharmaceutics. 8: 1381-9. PMID 21648427 DOI: 10.1021/Mp2002076  0.338
2011 Yang X, Peng Y, Yu B, Yu J, Zhou C, Mao Y, Lee LJ, Lee RJ. A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery. Molecular Pharmaceutics. 8: 709-15. PMID 21366344 DOI: 10.1021/Mp100272K  0.371
2011 Muthusamy N, Yu B, Mao Y, Bai L, Herman SE, Ramanunni A, Mo X, Jin Y, Carolyn C, Chan KK, Jarjoura D, Marcucci G, Lee RJ, Byrd JC, Lee LJ. 3.23 Targeted Nanoparticle Delivery Overcomes Off-Target Immunostimulatory Effects of Oligonucleotides and Improves Therapeutic Efficacy Clinical Lymphoma Myeloma and Leukemia. 11: S213. DOI: 10.1016/J.Clml.2011.09.112  0.517
2010 Zheng Y, Yu B, Weecharangsan W, Piao L, Darby M, Mao Y, Koynova R, Yang X, Li H, Xu S, Lee LJ, Sugimoto Y, Brueggemeier RW, Lee RJ. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. International Journal of Pharmaceutics. 390: 234-41. PMID 20156537 DOI: 10.1016/J.Ijpharm.2010.02.008  0.348
2010 Yu B, Mao Y, Bai L, Herman SE, Ramanunni A, Jin Y, Mo X, Cheney C, Chan KK, Jarjoura D, Marcucci G, Lee R, Lee L, Byrd JC, Muthusamy N. Liposomal Targeted Delivery Overcomes Immunostimulatory Effects of Oligonucleotide Based Therapy In Chronic Lymphocytic Leukemia. Blood. 116: 1475-1475. DOI: 10.1182/Blood.V116.21.1475.1475  0.593
Show low-probability matches.